NIH-funded research U01 cooperative agreement

Early heart and metabolic risk prediction in Africa

Official title: Integrated modeLs for Early Risk-prediction in Africa (ILERA) study

Funded at Wits Health Consortium (Pty), LTD · NIH-11415180 · Data updated 2026-11-12

This project combines genetic information, blood-based signals, and lifestyle details to improve prediction of heart and metabolic disease risk for people in African communities.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWits Health Consortium (Pty), LTD
NIH-funded
Lab location1 site (Parktown, South Africa)
Project startSeptember 20, 2023
Project endJuly 31, 2026
Funding year2025
Award (this year)$43,000
NIH project number3U01HL172182-03S1
Project IDNIH-11415180 on NIH RePORTER

Who could benefit from this research

Could help

Adults from participating African communities who are willing to provide blood samples and share lifestyle and environmental information are the ideal candidates.

Less likely to help

People who do not have African ancestry, are outside the study locations, or are unwilling to provide biological samples or lifestyle data may not benefit directly from this project.

What this research studies

If you take part, you may be asked to give a blood sample and answer questions about your diet, activity, and environment. Researchers will start from existing genetic risk scores and add layers such as predicted gene activity, blood markers, and lifestyle data. They will use data-driven models that can capture complex, non-linear relationships between genes, biology, and environment. The work focuses on African populations (with participating sites including Burkina Faso and coordination at WITS in South Africa) to make risk tools more accurate for people like you.

Why it matters

Potential benefit: If successful, this could help identify people at higher risk earlier so prevention or treatment can be offered sooner in African communities.

How similar studies have gone: Integrating genetics with other biological and lifestyle data has shown promise in non-African populations, but it remains relatively untested and less effective so far in African populations.

Where this research is happening

  • Wits Health Consortium (Pty), LTD
    Parktown, South Africa
    Active

Researchers

  • Principal investigator: Choudhury, Ananyo — Wits Health Consortium (Pty), LTD
  • Study coordinator: Choudhury, Ananyo

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.